What Drives Coca Cola Europacific (CCEP) Shares: Europe to Australia

Most investors know the red disc and the contour bottle, but far fewer know who actually fills the cans. Any Coca-Cola Europacific Partners (CCEP) stock analysis has to start with that distinction, because CCEP is not the company that owns the trademarks. It is the bottler: the organisation that buys concentrate, adds water, sugar and carbonation, packages the result, and then physically moves it to roughly four million customer outlets. That business model is unusual on the London market, and it produces a financial profile that looks very different from the brand owner it serves. CCEP operates across 31 countries and reaches close to 600 million consumers, spanning western Europe at one end and Australia, the Pacific and south-east Asia at the other.

What Coca-Cola Europacific Partners actually owns

CCEP holds long-term bottling agreements with The Coca-Cola Company (KO) that give it exclusive rights to prepare, package, distribute and sell Coca-Cola branded products within defined territories. The brand owner keeps the marketing equity and sells CCEP the concentrate; CCEP keeps the factories, the warehouses, the chilled cabinets in corner shops and the lorries. It is a capital-heavy, logistics-led business bolted onto one of the strongest consumer franchises in the world.

That structure explains a lot about the accounts. Revenue is large relative to the market value of the company because CCEP books the full retail-facing sales value of the drinks, not a royalty. Margins are mid-teens rather than the thirty-per-cent-plus territory the brand owner occupies. And the input line that matters most is not advertising but cost of sales per unit case, the blended cost of concentrate, sweetener, aluminium, PET and freight for each case sold. Diageo (DGE) sits at the other end of the same London drinks shelf, a brand owner whose margins rest on spirits it owns outright rather than on packaging and moving someone else's trademark.

The share register is also distinctive. The Coca-Cola Company itself holds roughly 19 per cent, and Olive Partners, the vehicle for the Daurella family's Spanish bottling interests, held 166,128,987 shares, around 36.1 per cent of issued capital, as at 3 April 2025. Between them those two holders control a majority, leaving a free float of well under half the register. For a FTSE 100 constituent that is an unusual ownership pattern, and it is a structural feature rather than a passing one.

Europe and the Asia Pacific arm pull in different ways

The group reports in two segments, and they behave differently. Europe is the mature, high-volume core: in the first half of 2026 it generated revenue of about €7.9bn, up 5.9 per cent as reported and 6.4 per cent on a currency-neutral basis, on volume of 1,308 million unit cases, up 1.6 per cent on a comparable basis. Growth here is overwhelmingly a price, packaging and mix story rather than a volume story. Selling more single-serve cans through convenience channels, and more zero-sugar and energy variants, lifts revenue per case even when the number of cases barely moves.

The Australia, Pacific and south-east Asia segment is the growth and complexity end. Its first-half revenue was around €2.81bn, up just 0.4 per cent as reported but 5.4 per cent currency-neutral, with operating profit of €348m, up 18.4 per cent as reported. The gap between those reported and currency-neutral revenue figures is the point: this is where translation effects bite hardest.

The segment also contains the group's most recent large acquisition. In February 2024 CCEP and Aboitiz Equity Ventures jointly acquired Coca-Cola Beverages Philippines, on a 60:40 basis, with 100 per cent of the business valued at 1.8 billion US dollars on a debt-free, cash-free basis. The entity was renamed Coca-Cola Europacific Aboitiz Philippines with effect from 13 January 2025. That deal moved CCEP meaningfully further into emerging-market territory, with a very different per-capita consumption profile, a different competitive set and a different margin starting point from Germany or Great Britain.

What the H1 2026 figures show

CCEP reported results for the six months ended 3 July 2026 on 4 August 2026. Because this is a UK-listed company that reports on a half-year rhythm, there is no quarterly earnings cycle to track in the American sense, though the group does publish a first-quarter trading update.

• Revenue: €10,724m, up 4.4 per cent as reported and 6.1 per cent currency-neutral.
• Volume: 2,041 million unit cases, up 5.6 per cent as reported but only 2.2 per cent on a comparable basis.
• Operating profit: €1,458m reported, up 6.9 per cent; €1,481m comparable, up 8.1 per cent currency-neutral.
• Comparable operating margin: 13.8 per cent.

The distance between the headline volume figure and the comparable one is worth pausing on. Reported volume growth of 5.6 per cent flatters the underlying trend; on a like-for-like basis the group sold roughly 2.2 per cent more cases. Revenue grew faster than volume in both framings, which is the signature of a bottler pushing price and mix rather than simply shifting more liquid.

Note also that CCEP reports in euros, not sterling. This is one of the traps in reading a London-listed share: the reporting currency, the currencies in which the drinks are actually sold, and the currency the shares are quoted in are three separate things. Currency-neutral figures strip out translation and are the cleaner read on trading performance; reported figures are what eventually lands in the accounts.

Cash, debt and the dividend

The full-year 2025 numbers give the cleaner annual baseline. Revenue was €20,901m, up 2.3 per cent as reported and 2.8 per cent on a comparable currency-neutral basis. Reported operating profit rose 31.0 per cent to €2,793m, with comparable operating profit of €2,808m up 7.1 per cent currency-neutral. Diluted earnings per share were €4.26 reported, up 38.3 per cent, and €4.11 comparable, up 6.2 per cent. The very large gap between reported and comparable growth is a reminder to check which basis a headline is quoting before drawing a conclusion from it.

Comparable free cash flow for 2025 was €1,836m. In the first half of 2026 comparable free cash flow was €435m, with net cash from operating activities of €1,035m. Half-year cash generation is seasonally lighter than the full year for a drinks business with a summer-weighted working capital cycle, so the half-year figure should not simply be doubled.

On the balance sheet, net debt stood at €10,284m at 3 July 2026, against €9,823m at the end of December 2025, with a €1.8bn undrawn credit facility available. That is a substantial debt load in absolute terms, and it is the natural consequence of a capital-intensive bottler that has also been buying businesses.

On distributions, CCEP declared a first-half interim dividend of €0.82 per share, payable on 27 May 2026 to shareholders on the register at 15 May 2026, equivalent to roughly 40 per cent of the 2025 full-year dividend of €2.04. The group also has a €1bn share buyback under way, of which €593m had been completed by 31 July 2026, with repurchases running across both the US and London lines. In the week ending 18 September 2026 the company repurchased 397,500 shares.

Management reaffirmed 2026 guidance at the half year: comparable revenue growth of 3 to 4 per cent, comparable operating profit growth of about 7 per cent, comparable free cash flow of at least €1.7bn, and an annualised dividend payout ratio of around 50 per cent. Guidance also assumes cost of sales per unit case rising about 1.5 per cent.

Listings, quotation and what the multiples measure

CCEP has an unusual listing footprint. It is a constituent of both the FTSE 100 and the Nasdaq-100, and the shares trade in New York in US dollars and in London in sterling. One detail catches people out: the London line is quoted in whole pounds per share, not in pence like most FTSE 100 constituents. During the week ending 18 September 2026, buyback purchases were executed in a London range of £74.45 to £78.05 per share and a New York range of 99.37 to 105.19 US dollars. Market capitalisation was reported at around £34.98bn on roughly 442.78 million shares in issue.

On valuation, one market data provider put CCEP on a trailing price-to-earnings ratio of 20.38 and a forward ratio of 19.19 as at 3 September 2026. It is worth being precise about what that measures. A price-to-earnings multiple compares the share price with earnings per share; the trailing version uses earnings already reported, the forward version uses a consensus estimate of earnings not yet delivered. For a bottler, the multiple has to be read alongside the debt: equity-only measures ignore the €10bn-plus of net borrowings that sits ahead of shareholders in the capital structure, which is why enterprise-value measures are often used for comparison across this sector.

Risks and what to watch from here

Several things could reasonably change the picture, and they are worth separating into structural and cyclical.

• Input costs. Aluminium, PET resin, sugar and freight all feed cost of sales per unit case. The guidance assumption of about 1.5 per cent growth in that line is a specific, checkable number; a material deviation would move the margin.
• Currency translation. With euro reporting and a large Asia Pacific footprint, the gap between reported and currency-neutral growth is a permanent feature. It has been running at roughly two percentage points at the revenue line in recent periods.
• Volume versus price. Comparable volume growth of 2.2 per cent in the first half did most of its work below the revenue line. If price and mix ever stop offsetting flat cases, revenue growth slows quickly.
• Regulation and taxation. Sugar levies, deposit return schemes and packaging rules apply differently in each of the 31 countries CCEP serves, and compliance costs land on the bottler rather than the brand owner.
• The franchise relationship. CCEP's rights derive from bottling agreements with The Coca-Cola Company. The terms of that relationship, and the concentrate pricing within it, are a structural dependency that no bottler fully controls. Peer bottlers such as Coca-Cola HBC (CCH) face the same dependency.
• Debt and capital allocation. With net debt above €10bn and a buyback running alongside a roughly 50 per cent payout ratio, the balance between deleveraging, distributions and further acquisitions is the decision to monitor.

The picture that emerges from this Coca-Cola Europacific Partners share price analysis is of a business with a genuinely defensible franchise position, mid-teens operating margins, visible cash generation and a heavy balance sheet, growing revenue faster than volume across two regions that are at different stages of development. The specific items to watch over the next reporting cycle are straightforward: whether cost of sales per unit case holds near the guided 1.5 per cent, whether comparable volume stays positive in Europe, whether the Asia Pacific and south-east Asia segment keeps converting currency-neutral revenue growth into reported profit growth, and whether free cash flow builds towards the €1.7bn full-year commitment. Those four lines, read together with the direction of net debt, will tell an investor more about how the business is actually travelling than any single headline figure.